Company news

ONO Pharmaceutical Co., Ltd. news in 2025

ONO Pharmaceutical Co., Ltd.'s news releases, calls and decks from 2025, newest first.

View company

Ono Pharmaceutical Receives Highest A-List Rating in CDP 2025 Report for Climate Change and Water Security Efforts

December 10, 2025

Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting

December 6, 2025

Ono Pharmaceutical Receives Supplemental Approval of Combination Therapy with BRAFTOVI® Capsule, a BRAF Inhibitor, for the Indication of Colorectal Cancer

November 20, 2025

PRISM BioLab Achieved Initial Milestone and Receives the Milestone Payment in Drug Discovery Collaboration with Ono Pharmaceutical Co., Ltd.

November 14, 2025

ONO Pharmaceutical: Updated Global Phase 1/2 Clinical Trial Data for Povetacicept, which was Granted Breakthrough Therapy Designation in IgA Nephropathy and Fast Track Designation in Primary Membranous Nephropathy from FDA

November 10, 2025

Ono Announces ONO-4578 in Combination with Opdivo and Chemotherapy Met the Primary Endpoint in a Phase 2 Clinical Trial in Patients with Certain Gastric Cancer

October 9, 2025

Ono Pharmaceutical Announces -4578 (EP4 antagonist) in Combination with Opdivo and Chemotherapy Met the Primary Endpoint in a Phase 2 Clinical Trial in Patients with Certain Gastric Cancer

October 8, 2025

Ono Pharmaceutical Announces Encouraging Efficacy Signals of -2808, a S1P5 Receptor Agonist, in an interim analysis of Ongoing Phase 2 Clinical Trial in Patients with Multiple System Atrophy

October 8, 2025

Harness Therapeutics Announces Launch of MISBA® Duo Platform and Research Collaboration with Ono Venture Investment

October 6, 2025

Ono Pharmaceutical Submits an Application for Approval of Cenobamate (-2017), Antiseizure Medications in Japan

September 30, 2025

Deciphera Announces Positive CHMP Opinion for ROMVIMZA™ (vimseltinib) for the Treatment of Tenosynovial Giant Cell Tumor (TGCT)

July 28, 2025

Vertex and Ono Pharmaceutical Announce Strategic Agreement to Develop and Commercialize Povetacicept in Japan and South Korea

June 23, 2025

Decks in 2025